脂蛋白脂酶
遗传学
生物
先证者
突变
等位基因
创始人效应
基因
家族性高胆固醇血症
脂肪酶
移码突变
杂合子优势
内分泌学
脂蛋白
遗传异质性
遗传性胰腺炎
胰腺炎
甘油三酯酶
遗传连锁
内科学
印地语III
酶
疾病
作者
Bunge, S.,Kleijer, W. J.,Tylki-Szymanska, A.,Steglich, C.,Beck, M.,Tomatsu, S.,Fukuda, S.,Ben J. H. M. Poorthuis,Czartoryska, B.,Orii, T.,Gal, A.
标识
DOI:10.1002/(sici)1098-1004(1997)10:3
摘要
Lipoprotein lipase (LPL) is the rate-limiting enzyme for the hydrolysis of triglyceride-rich lipoproteins. Numerous LPL gene mutations have been described as a cause of familial chylomicronemia in various populations. In general, allelic heterogeneity is observed in LPL deficiency in different populations. However, a founder effect has been reported in certain populations, such as French Canadians. Although familial chylomicronemia is observed in Morocco, the molecular basis for the disease remains unknown. Here, we report two unrelated Moroccan families of Berber ancestry, ascertained independently in Holland and France. In both probands, familial chylomicronemia manifested in infancy and was complicated with acute pancreatitis at age 2 years. Both probands were homozygous for a Ser259Arg mutation, which results in the absence of LPL catalytic activity both in vivo and in vitro. In heterozygous relatives, a partial decrease in plasma LPL activity was observed, sometimes associated with combined hyperlipidemia. This mutation previously unreported in other populations segregated on an identical haplotype, rarely observed in Caucasians, in both families. Therefore, LPL deficiency is a cause of familial chylomicronemia in Morocco and may result from a founder effect in patients of Berber ancestry
科研通智能强力驱动
Strongly Powered by AbleSci AI